Compare

Cencora vs McKesson

MonkScore ranges and fundamentals, side by side

Key facts

Cencora and McKesson: key facts

  • In fiscal 2025, Cencora, Inc. reported revenue of $321.3B and net income of $1.6B.
  • In fiscal 2026, McKesson Corporation reported revenue of $403.4B and net income of $4.8B.
  • Cencora, Inc.'s revenue grew 10.7% a year from fiscal 2021 to fiscal 2025.
  • McKesson Corporation's revenue grew 11.2% a year from fiscal 2022 to fiscal 2026.
  • Cencora, Inc.'s free cash flow was positive in 5 of the 5 fiscal years from 2021 to 2025.
  • McKesson Corporation's free cash flow was positive in 5 of the 5 fiscal years from 2022 to 2026.
  • In the twelve months to 30 June 2026, Cencora, Inc. reported revenue of $332.8B and net income of $2.6B.
  • In the twelve months to 30 June 2026, McKesson Corporation reported revenue of $411.0B and net income of $4.6B.

Side by side

Cencora and McKesson, side by side

Each figure is in the company's reporting currency, with its fiscal year or the date of its last report.

FigureCencora, Inc.NYSE:CORMcKesson CorporationNYSE:MCK
MonkScore
MonkScore range70–80as of October 202670–80as of October 2026
Sector rank190 of 628 in Healthcare206 of 628 in Healthcare
How this score is madeDisclaimer
Profile
SectorHealthcareHealthcare
IndustryMedical - DistributionMedical - Distribution
Latest fiscal year
Revenue$321.3BFY 2025$403.4BFY 2026
Net income$1.6BFY 2025$4.8BFY 2026
Free cash flow$3.2BFY 2025$5.4BFY 2026
Operating cash flow$3.9BFY 2025$6.2BFY 2026
Total debt$10.7BFY 2025$8.6BFY 2026
Cash$4.4BFY 2025$4.0BFY 2026
Last 12 months
Revenue$332.8Bto 30 June 2026$411.0Bto 30 June 2026
Net income$2.6Bto 30 June 2026$4.6Bto 30 June 2026
Free cash flow$4.1Bto 30 June 2026$6.2Bto 30 June 2026
Operating cash flow$4.8Bto 30 June 2026$6.9Bto 30 June 2026
Total debt$11.7Bto 30 June 2026$11.7Bto 30 June 2026
Cash$2.8Bto 30 June 2026$5.2Bto 30 June 2026

MonkStreet provides research, not investment advice.